Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 164

1.

Joint UK societies' 2019 consensus statement on renal denervation.

Lobo MD, Sharp ASP, Kapil V, Davies J, de Belder MA, Cleveland T, Bent C, Chapman N, Dasgupta I, Levy T, Mathur A, Matson M, Saxena M, Cappuccio FP; British & Irish Hypertension Society, the British Cardiovascular Society, the British Cardiovascular Intervention Society, the British Society of Interventional Radiology and the Renal Association.

Heart. 2019 Oct;105(19):1456-1463. doi: 10.1136/heartjnl-2019-315098. Epub 2019 Jul 10. Review.

2.

Rapid Aspirin Desensitization is Safe and Feasible in Patients With Stable and Unstable Coronary Artery Disease: A Single-Center Experience.

Jackson M, Callaghan S, Stapleton J, Bolton S, Austin D, Muir DF, Sutton AGC, Wright RA, Williams PD, Hall JA, Carter J, de Belder MA, Swanson N.

J Cardiovasc Pharmacol Ther. 2019 Jul;24(4):359-364. doi: 10.1177/1074248418823016. Epub 2019 Jan 6.

PMID:
30614246
3.

Percutaneous coronary intervention in cancer patients: a report of the prevalence and outcomes in the United States.

Potts JE, Iliescu CA, Lopez Mattei JC, Martinez SC, Holmvang L, Ludman P, De Belder MA, Kwok CS, Rashid M, Fischman DL, Mamas MA.

Eur Heart J. 2019 Jun 7;40(22):1790-1800. doi: 10.1093/eurheartj/ehy769.

PMID:
30500952
4.

Changes in Periprocedural Bleeding Complications Following Percutaneous Coronary Intervention in The United Kingdom Between 2006 and 2013 (from the British Cardiovascular Interventional Society).

Olier I, Carr M, Curzen N, Ludman P, Baumbach A, Kinnaird T, de Belder MA, Hildick-Smith D, Sirker A, Kwok CS, Rashid M, Nolan J, Kontopantelis E, Mamas MA.

Am J Cardiol. 2018 Sep 15;122(6):952-960. doi: 10.1016/j.amjcard.2018.06.016. Epub 2018 Jul 8.

PMID:
30131105
5.

Outcomes after culprit-only percutaneous coronary intervention for multivessel disease during ST-segment elevation myocardial infarction: a comparison of registry and clinical trial outcomes.

Jackson MWP, Austin D, Swanson N, Williams PD, Muir DF, Hall JA, Wright RA, Sutton AGC, Carter J, de Belder MA.

Coron Artery Dis. 2018 Nov;29(7):564-572. doi: 10.1097/MCA.0000000000000646.

PMID:
29944476
6.

Transcatheter aortic valve implantation for aortic stenosis in high surgical risk patients: A systematic review and meta-analysis.

Liu Z, Kidney E, Bem D, Bramley G, Bayliss S, de Belder MA, Cummins C, Duarte R.

PLoS One. 2018 May 10;13(5):e0196877. doi: 10.1371/journal.pone.0196877. eCollection 2018. Review.

7.

Transradial Secondary Access to Guide Valve Implantation and Manage Peripheral Vascular Complications During Transcatheter Aortic Valve Implantation.

Jackson MWP, Muir DF, de Belder MA, Palmer S, Owens WA, Goodwin A, Hayat U, Williams PD.

Heart Lung Circ. 2019 Apr;28(4):637-646. doi: 10.1016/j.hlc.2018.02.025. Epub 2018 Mar 10.

PMID:
29685717
8.

Operator volume is not associated with mortality following percutaneous coronary intervention: insights from the British Cardiovascular Intervention Society registry.

Hulme W, Sperrin M, Curzen N, Kinnaird T, De Belder MA, Ludman P, Kwok CS, Gale CP, Cockburn J, Kontopantelis E, Mamas MA; British Cardiovascular Intervention Society and the National Institute of Cardiovascular Outcomes Research.

Eur Heart J. 2018 May 7;39(18):1623-1634. doi: 10.1093/eurheartj/ehy125.

PMID:
29579219
9.

Retroperitoneal Hemorrhage After Percutaneous Coronary Intervention: Incidence, Determinants, and Outcomes as Recorded by the British Cardiovascular Intervention Society.

Kwok CS, Kontopantelis E, Kinnaird T, Potts J, Rashid M, Shoaib A, Nolan J, Bagur R, de Belder MA, Ludman P, Mamas MA; British Cardiovascular Intervention Society (BCIS) and National Institute of Cardiovascular Outcomes Research (NICOR).

Circ Cardiovasc Interv. 2018 Feb;11(2):e005866. doi: 10.1161/CIRCINTERVENTIONS.117.005866.

PMID:
29445000
10.

Association of different antiplatelet therapies with mortality after primary percutaneous coronary intervention.

Olier I, Sirker A, Hildick-Smith DJR, Kinnaird T, Ludman P, de Belder MA, Baumbach A, Byrne J, Rashid M, Curzen N, Mamas MA; British Cardiovascular Intervention Society and the National Institute for Cardiovascular Outcomes Research.

Heart. 2018 Oct;104(20):1683-1690. doi: 10.1136/heartjnl-2017-312366. Epub 2018 Feb 2.

PMID:
29437885
11.

Antiplatelet drug selection in PCI to vein grafts in patients with acute coronary syndrome and adverse clinical outcomes: Insights from the British Cardiovascular Intervention Society database.

Sirker A, Kwok CS, Kontopantelis E, Johnson T, Freeman P, de Belder MA, Ludman P, Zaman A, Mamas MA.

Catheter Cardiovasc Interv. 2018 Oct 1;92(4):659-665. doi: 10.1002/ccd.27493. Epub 2018 Jan 22.

PMID:
29356278
12.

Novel United Kingdom prognostic model for 30-day mortality following transcatheter aortic valve implantation.

Martin GP, Sperrin M, Ludman PF, de Belder MA, Redwood SR, Townend JN, Gunning M, Moat NE, Banning AP, Buchan I, Mamas MA.

Heart. 2018 Jul;104(13):1109-1116. doi: 10.1136/heartjnl-2017-312489. Epub 2017 Dec 7.

13.

Impact of Access Site Practice on Clinical Outcomes in Patients Undergoing Percutaneous Coronary Intervention Following Thrombolysis for ST-Segment Elevation Myocardial Infarction in the United Kingdom: An Insight From the British Cardiovascular Intervention Society Dataset.

Rashid M, Rushton CA, Kwok CS, Kinnaird T, Kontopantelis E, Olier I, Ludman P, De Belder MA, Nolan J, Mamas MA.

JACC Cardiovasc Interv. 2017 Nov 27;10(22):2258-2265. doi: 10.1016/j.jcin.2017.07.049.

14.

Acute and one-year clinical outcomes following implantation of bioresorbable vascular scaffolds: the ABSORB UK Registry.

Baumbach A, Zaman A, West NEJ, O'Kane P, Egred M, Johnson T, Wheatcroft S, Bowles R, de Belder A, Bouras G, Lansky A, Hill J, Mathur A, de Belder MA, Banning AP.

EuroIntervention. 2018 Jan 20;13(13):1554-1560. doi: 10.4244/EIJ-D-17-00886.

15.

Relative Survival After Transcatheter Aortic Valve Implantation: How Do Patients Undergoing Transcatheter Aortic Valve Implantation Fare Relative to the General Population?

Martin GP, Sperrin M, Hulme W, Ludman PF, de Belder MA, Toff WD, Alabas O, Moat NE, Doshi SN, Buchan I, Deanfield JE, Gale CP, Mamas MA; National Institute of Cardiovascular Outcomes Research (NICOR).

J Am Heart Assoc. 2017 Oct 17;6(10). pii: e007229. doi: 10.1161/JAHA.117.007229.

16.

The Relationship of Body Mass Index to Percutaneous Coronary Intervention Outcomes: Does the Obesity Paradox Exist in Contemporary Percutaneous Coronary Intervention Cohorts? Insights From the British Cardiovascular Intervention Society Registry.

Holroyd EW, Sirker A, Kwok CS, Kontopantelis E, Ludman PF, De Belder MA, Butler R, Cotton J, Zaman A, Mamas MA; British Cardiovascular Intervention Society and National Institute of Cardiovascular Outcomes Research.

JACC Cardiovasc Interv. 2017 Jul 10;10(13):1283-1292. doi: 10.1016/j.jcin.2017.03.013.

17.

United Kingdom: coronary and structural heart interventions from 2010 to 2015.

Ludman PF, de Belder MA, Redwood S, Banning A.

EuroIntervention. 2017 May 15;13(Z):Z83-Z88. doi: 10.4244/EIJ-D-16-00833.

PMID:
28504238
18.

Aortic stenosis and non-cardiac surgery: A systematic review and meta-analysis.

Kwok CS, Bagur R, Rashid M, Lavi R, Cibelli M, de Belder MA, Moat N, Hildick-Smith D, Ludman P, Mamas MA.

Int J Cardiol. 2017 Aug 1;240:145-153. doi: 10.1016/j.ijcard.2017.04.037. Epub 2017 Apr 12. Review.

PMID:
28431770
19.

Choice of Stent for Percutaneous Coronary Intervention of Saphenous Vein Grafts.

Iqbal J, Kwok CS, Kontopantelis E, de Belder MA, Ludman PF, Large A, Butler R, Gamal A, Kinnaird T, Zaman A, Mamas MA; British Cardiovascular Intervention Society (BCIS) and National Institute of Cardiovascular Outcome Research (NICOR).

Circ Cardiovasc Interv. 2017 Apr;10(4). pii: e004457. doi: 10.1161/CIRCINTERVENTIONS.116.004457.

PMID:
28404622
20.

Total Center Percutaneous Coronary Intervention Volume and 30-Day Mortality: A Contemporary National Cohort Study of 427 467 Elective, Urgent, and Emergency Cases.

O'Neill D, Nicholas O, Gale CP, Ludman P, de Belder MA, Timmis A, Fox KA, Simpson IA, Redwood S, Ray SG.

Circ Cardiovasc Qual Outcomes. 2017 Mar;10(3). pii: e003186. doi: 10.1161/CIRCOUTCOMES.116.003186. Erratum in: Circ Cardiovasc Qual Outcomes. 2017 Aug;10(8):.

21.

Inadequacy of existing clinical prediction models for predicting mortality after transcatheter aortic valve implantation.

Martin GP, Sperrin M, Ludman PF, de Belder MA, Gale CP, Toff WD, Moat NE, Trivedi U, Buchan I, Mamas MA.

Am Heart J. 2017 Feb;184:97-105. doi: 10.1016/j.ahj.2016.10.020. Epub 2016 Nov 3.

22.

Pre-Implantation Balloon Aortic Valvuloplasty and Clinical Outcomes Following Transcatheter Aortic Valve Implantation: A Propensity Score Analysis of the UK Registry.

Martin GP, Sperrin M, Bagur R, de Belder MA, Buchan I, Gunning M, Ludman PF, Mamas MA.

J Am Heart Assoc. 2017 Feb 18;6(2). pii: e004695. doi: 10.1161/JAHA.116.004695.

23.

Left Atrial Appendage Thrombus in Transcatheter Aortic Valve Replacement: Incidence, Clinical Impact, and the Role of Cardiac Computed Tomography.

Palmer S, Child N, de Belder MA, Muir DF, Williams P.

JACC Cardiovasc Interv. 2017 Jan 23;10(2):176-184. doi: 10.1016/j.jcin.2016.10.043.

25.

Transcatheter Aortic Valve Implantation With or Without Preimplantation Balloon Aortic Valvuloplasty: A Systematic Review and Meta-Analysis.

Bagur R, Kwok CS, Nombela-Franco L, Ludman PF, de Belder MA, Sponga S, Gunning M, Nolan J, Diamantouros P, Teefy PJ, Kiaii B, Chu MW, Mamas MA.

J Am Heart Assoc. 2016 Jun 13;5(6). pii: e003191. doi: 10.1161/JAHA.115.003191. Review. Erratum in: J Am Heart Assoc. 2016;5(9). pii: e002102. doi: 10.1161/JAHA.116.002102.

26.

Impact of call-to-balloon time on 30-day mortality in contemporary practice.

Varcoe RW, Clayton TC, Gray HH, de Belder MA, Ludman PF, Henderson RA; British Cardiovascular Intervention Society (BCIS) and the National Institute for Cardiovascular Outcomes Research (NICOR).

Heart. 2017 Jan 15;103(2):117-124. doi: 10.1136/heartjnl-2016-309658. Epub 2016 Jul 13.

27.

Relationship Between Femoral Vascular Closure Devices and Short-Term Mortality From 271 845 Percutaneous Coronary Intervention Procedures Performed in the United Kingdom Between 2006 and 2011: A Propensity Score-Corrected Analysis From the British Cardiovascular Intervention Society.

Farooq V, Goedhart D, Ludman P, de Belder MA, Harcombe A, El-Omar M; British Cardiovascular Intervention Society and the National Institute for Cardiovascular Outcomes Research.

Circ Cardiovasc Interv. 2016 Jun;9(6). pii: e003560. doi: 10.1161/CIRCINTERVENTIONS.116.003560.

PMID:
27225421
28.

Direct transfemoral transcatheter aortic valve implantation without balloon pre-dilatation using the Edwards Sapien XT valve.

Bandali A, Parry-Williams G, Kassam A, Palmer S, Williams PD, de Belder MA, Owens A, Goodwin A, Muir DF.

Catheter Cardiovasc Interv. 2016 Nov 15;88(6):978-985. doi: 10.1002/ccd.26564. Epub 2016 May 18.

PMID:
27189391
29.

Determinants and Outcomes of Stroke Following Percutaneous Coronary Intervention by Indication.

Myint PK, Kwok CS, Roffe C, Kontopantelis E, Zaman A, Berry C, Ludman PF, de Belder MA, Mamas MA; British Cardiovascular Intervention Society and the National Institute for Cardiovascular Outcomes Research.

Stroke. 2016 Jun;47(6):1500-7. doi: 10.1161/STROKEAHA.116.012700. Epub 2016 May 10.

PMID:
27165953
30.

The SSTARS (STeroids and Stents Against Re-Stenosis) Trial: Different stent alloys and the use of peri-procedural oral corticosteroids to prevent in-segment restenosis after percutaneous coronary intervention.

Adam Z, Turley A, Mason JM, Kasim AS, Newby D, Mills N, Padfield G, Thompson L, Morley R, Hall JA, Wright RA, Muir DF, Sutton AG, Swanson N, Carter J, Bilous R, Jones S, de Belder MA.

Int J Cardiol. 2016 Aug 1;216:1-8. doi: 10.1016/j.ijcard.2016.04.105. Epub 2016 Apr 29.

PMID:
27135149
31.

Outcomes Following Primary Percutaneous Coronary Intervention in Patients With Previous Coronary Artery Bypass Surgery.

Iqbal J, Kwok CS, Kontopantelis E, de Belder MA, Ludman PF, Giannoudi M, Gunning M, Zaman A, Mamas MA; British Cardiovascular Intervention Society (BCIS) and the National Institute for Cardiovascular Outcomes Research (NICOR).

Circ Cardiovasc Interv. 2016 Apr;9(4):e003151. doi: 10.1161/CIRCINTERVENTIONS.115.003151.

PMID:
27069103
32.

Changes in Arterial Access Site and Association With Mortality in the United Kingdom: Observations From a National Percutaneous Coronary Intervention Database.

Mamas MA, Nolan J, de Belder MA, Zaman A, Kinnaird T, Curzen N, Kwok CS, Buchan I, Ludman P, Kontopantelis E; British Cardiovascular Intervention Society (BCIS) and the National Institute for Clinical Outcomes Research (NICOR).

Circulation. 2016 Apr 26;133(17):1655-67. doi: 10.1161/CIRCULATIONAHA.115.018083. Epub 2016 Mar 11.

PMID:
26969759
33.

A contemporary risk model for predicting 30-day mortality following percutaneous coronary intervention in England and Wales.

McAllister KS, Ludman PF, Hulme W, de Belder MA, Stables R, Chowdhary S, Mamas MA, Sperrin M, Buchan IE; British Cardiovascular Intervention Society and the National Institute for Cardiovascular Outcomes Research.

Int J Cardiol. 2016 May 1;210:125-32. doi: 10.1016/j.ijcard.2016.02.085. Epub 2016 Feb 17.

34.

Does Direct Transcatheter Aortic Valve Replacement Increase the Risk of Cerebral Embolization?

Palmer S, Muir DF, de Belder MA, Williams P.

JACC Cardiovasc Interv. 2016 Feb 8;9(3):302-303. doi: 10.1016/j.jcin.2015.11.013. No abstract available.

35.

Impact of operator volume for percutaneous coronary intervention on clinical outcomes: what do the numbers say?

Rashid M, Sperrin M, Ludman PF, O'Neill D, Nicholas O, de Belder MA, Mamas MA.

Eur Heart J Qual Care Clin Outcomes. 2016 Jan 1;2(1):16-22. doi: 10.1093/ehjqcco/qcv030.

PMID:
29474590
36.

Prognostic impact of percutaneous coronary intervention in stable coronary disease.

de Belder MA.

Eur Heart J Qual Care Clin Outcomes. 2016 Jan 1;2(1):1-3. doi: 10.1093/ehjqcco/qcv026. No abstract available.

PMID:
29474589
37.

Bivalirudin, glycoprotein inhibitor, and heparin use and association with outcomes of primary percutaneous coronary intervention in the United Kingdom.

Sirker A, Mamas M, Robinson D, Anderson SG, Kinnaird T, Stables R, de Belder MA, Ludman P, Hildick-Smith D.

Eur Heart J. 2016 Apr 21;37(16):1312-20. doi: 10.1093/eurheartj/ehv631. Epub 2015 Dec 18.

PMID:
26685133
38.

Embolization of Left Atrial Appendage Thrombus During Transcatheter Aortic Valve Replacement: A Potential Mechanism of Periprocedural Stroke.

Williams PD, de Belder MA, Maredia N, Muir DF.

JACC Cardiovasc Interv. 2015 Nov;8(13):1770-1. doi: 10.1016/j.jcin.2015.07.025. No abstract available.

39.

Comparative survival after transapical, direct aortic, and subclavian transcatheter aortic valve implantation (data from the UK TAVI registry).

Fröhlich GM, Baxter PD, Malkin CJ, Scott DJ, Moat NE, Hildick-Smith D, Cunningham D, MacCarthy PA, Trivedi U, de Belder MA, Ludman PF, Blackman DJ; National Institute for Cardiovascular Outcomes Research.

Am J Cardiol. 2015 Nov 15;116(10):1555-9. doi: 10.1016/j.amjcard.2015.08.035. Epub 2015 Sep 3.

40.

National initiatives to improve outcomes from out-of-hospital cardiac arrest in England.

Perkins GD, Lockey AS, de Belder MA, Moore F, Weissberg P, Gray H; Community Resuscitation Group.

Emerg Med J. 2016 Jul;33(7):448-51. doi: 10.1136/emermed-2015-204847. Epub 2015 Sep 23. No abstract available.

41.

Effect of access site, gender, and indication on clinical outcomes after percutaneous coronary intervention: Insights from the British Cardiovascular Intervention Society (BCIS).

Kwok CS, Kontopantelis E, Kunadian V, Anderson S, Ratib K, Sperrin M, Zaman A, Ludman PF, de Belder MA, Nolan J, Mamas MA; British Cardiovascular Intervention Society; National Institute for Cardiovascular Outcomes Research.

Am Heart J. 2015 Jul;170(1):164-72, 172.e1-5. doi: 10.1016/j.ahj.2015.04.018. Epub 2015 Apr 18.

PMID:
26093878
42.

Prevalence and Impact of Co-morbidity Burden as Defined by the Charlson Co-morbidity Index on 30-Day and 1- and 5-Year Outcomes After Coronary Stent Implantation (from the Nobori-2 Study).

Mamas MA, Fath-Ordoubadi F, Danzi GB, Spaepen E, Kwok CS, Buchan I, Peek N, de Belder MA, Ludman PF, Paunovic D, Urban P.

Am J Cardiol. 2015 Aug 1;116(3):364-71. doi: 10.1016/j.amjcard.2015.04.047. Epub 2015 May 8.

PMID:
26037294
43.

Stroke following percutaneous coronary intervention: type-specific incidence, outcomes and determinants seen by the British Cardiovascular Intervention Society 2007-12.

Kwok CS, Kontopantelis E, Myint PK, Zaman A, Berry C, Keavney B, Nolan J, Ludman PF, de Belder MA, Buchan I, Mamas MA; British Cardiovascular Intervention Society; National Institute for Cardiovascular Outcomes Research.

Eur Heart J. 2015 Jul 1;36(25):1618-28. doi: 10.1093/eurheartj/ehv113. Epub 2015 Apr 20.

PMID:
25896077
44.

Access and non-access site bleeding after percutaneous coronary intervention and risk of subsequent mortality and major adverse cardiovascular events: systematic review and meta-analysis.

Kwok CS, Khan MA, Rao SV, Kinnaird T, Sperrin M, Buchan I, de Belder MA, Ludman PF, Nolan J, Loke YK, Mamas MA.

Circ Cardiovasc Interv. 2015 Apr;8(4). pii: e001645. doi: 10.1161/CIRCINTERVENTIONS.114.001645. Review.

PMID:
25825007
45.

Blood transfusion after percutaneous coronary intervention and risk of subsequent adverse outcomes: a systematic review and meta-analysis.

Kwok CS, Sherwood MW, Watson SM, Nasir SB, Sperrin M, Nolan J, Kinnaird T, Kiatchoosakun S, Ludman PF, de Belder MA, Rao SV, Mamas MA.

JACC Cardiovasc Interv. 2015 Mar;8(3):436-446. doi: 10.1016/j.jcin.2014.09.026. Epub 2015 Feb 18. Review.

46.

Impact of age on access site-related outcomes in 469,983 percutaneous coronary intervention procedures: Insights from the British Cardiovascular Intervention Society.

Anderson SG, Ratib K, Myint PK, Keavney B, Kwok CS, Zaman A, Ludman PF, de Belder MA, Nolan J, Mamas MA; British Cardiovascular Intervention Society; National Institute for Cardiovascular Outcomes Research.

Catheter Cardiovasc Interv. 2015 Nov 15;86(6):965-72. doi: 10.1002/ccd.25896. Epub 2015 Feb 25.

PMID:
25676689
47.

Transcatheter aortic valve implantation in the United Kingdom: temporal trends, predictors of outcome, and 6-year follow-up: a report from the UK Transcatheter Aortic Valve Implantation (TAVI) Registry, 2007 to 2012.

Ludman PF, Moat N, de Belder MA, Blackman DJ, Duncan A, Banya W, MacCarthy PA, Cunningham D, Wendler O, Marlee D, Hildick-Smith D, Young CP, Kovac J, Uren NG, Spyt T, Trivedi U, Howell J, Gray H; UK TAVI Steering Committee and the National Institute for Cardiovascular Outcomes Research.

Circulation. 2015 Mar 31;131(13):1181-90. doi: 10.1161/CIRCULATIONAHA.114.013947. Epub 2015 Jan 30.

PMID:
25637628
48.

Impact of renal function on survival after transcatheter aortic valve implantation (TAVI): an analysis of the UK TAVI registry.

Ferro CJ, Chue CD, de Belder MA, Moat N, Wendler O, Trivedi U, Ludman P, Townend JN; UK TAVI Steering Group; National Institute for Cardiovascular Outcomes Research.

Heart. 2015 Apr;101(7):546-52. doi: 10.1136/heartjnl-2014-307041. Epub 2015 Jan 12.

PMID:
25582121
49.

Impact of left ventricular function and transaortic gradient on outcomes from transcatheter aortic valve implantation: data from the UK TAVI Registry.

Malkin CJ, Long WR, Baxter PD, Gale CP, Wendler O, Monaghan M, Thomas MT, Ludman PF, de Belder MA, Cunningham AD, Moat NE, Blackman DJ; National Institute for Cardiovascular Outcomes Research (NICOR).

EuroIntervention. 2016 Feb;11(10):1161-9. doi: 10.4244/EIJY14M12_12.

50.

Joint UK societies' 2014 consensus statement on renal denervation for resistant hypertension.

Lobo MD, de Belder MA, Cleveland T, Collier D, Dasgupta I, Deanfield J, Kapil V, Knight C, Matson M, Moss J, Paton JF, Poulter N, Simpson I, Williams B, Caulfield MJ; British Hypertension Society; British Cardiovascular Society; British Cardiovascular Intervention Society; Renal Association.

Heart. 2015 Jan;101(1):10-6. doi: 10.1136/heartjnl-2014-307029. Epub 2014 Nov 27.

Supplemental Content

Loading ...
Support Center